What is Alpha Formulations?
Founded in 2015, Alpha Formulations operates as a specialized manufacturer of soft gel capsules, serving as a vital link in the global health and wellness supply chain. The company distinguishes itself through deep technical expertise and robust operational capabilities, which allow it to meet the rigorous demands of high-volume product manufacturing. By maintaining close collaborative relationships with leading industry players, Alpha Formulations consistently integrates the most current technological advancements into its production processes, effectively bridging the gap between complex formulation requirements and scalable market delivery.
How much funding has Alpha Formulations raised?
Alpha Formulations has raised a total of $37K across 1 funding round:
Debt
$37K
Debt (2021): $37K with participation from PPP
Key Investors in Alpha Formulations
PPP
Public-Private Partnership
What's next for Alpha Formulations?
With the successful acquisition of this latest financing, Alpha Formulations is poised to accelerate its strategic roadmap, focusing on the optimization of its manufacturing facilities and the potential expansion of its service portfolio. The company's current lifecycle stage, identified as a significant Series B/C equivalent, suggests a shift toward aggressive market penetration and the scaling of its proprietary encapsulation methodologies. Future initiatives will likely prioritize the enhancement of operational efficiencies and the pursuit of long-term partnerships with global pharmaceutical entities, further cementing its status as a leader in the soft gel manufacturing sector.
See full Alpha Formulations company page
